Catamaran Corporation (NASDAQ:CTRX)

CAPS Rating: 5 out of 5

The Company provides healthcare information technology solutions and pharmacy benefit management services to the pharmaceutical supply chain in the US and Canada.


Player Avatar TMFInnovator (41.04) Submitted: 5/7/2013 11:00:14 AM : Outperform Start Price: $51.89 CTRX Score: -32.10

Classic disruptor that has been successful. There is a lot to like in this business.Strengths- Transparent business model is disruptive to the traditional PBM market. - CTRX's technology is superior to competitors. - Now that they are established in difficult customer segments (public-sector institutions and state Medicaid claims), there are high switching costs for customers to leave.Opportunities - Healthcare reform is putting a lot of pressure on Managed Care Organizations to take costs out of the system (which would reduce costs to the final consumers). - The flood of generics into pharmaceuticals offers opportunity for PBM's to take additional costs out. Reducing costs is a huge opportunity for Catamaran. Their fixed-price, transparent business model is aligned with the direction the industry appears to be heading. If they can upsell to larger clients, they could go from disruptor to the industry standard.

Featured Broker Partners